The future of the Pap: where is cervical cancer screening headed?
Ruhl
Catherine
C
AWHONN, Washington, DC, USA. cruhl@awhonn.org
D005260:Female; D006801:Humans; D008403:Mass Screening / Q000706:statistics & numerical data / Q000639:trends*; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D011322:Primary Prevention / Q000639:trends*; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control; D014626:Vaginal Smears / Q000706:statistics & numerical data / Q000639:trends*; D016387:Women's Health; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control
D053918:Papillomavirus Vaccines